Otsuka Pharmaceutical and Jolly Good team-up over VR product development
Jolly Good's immersive SST VR is expected to help patients concentrate better and improve effectiveness.
FDA asks for more tests before it approves Proteus-Otsuka’s sensor-equipped pill
The two companies submitted the system as a new drug application (NDA) with the FDA in September 2015, and the Agency now declined to approve it.
First digital medicine starts its journey with the FDA
A drug/device product combines Otsuka's ABILIFY for serious mental illness, embedded with the Proteus ingestible sensor in a single tablet to record ingestion.